Literature DB >> 22153586

Successful outcome of two pregnancies in patients with adult-onset Still's disease treated with IL-1 receptor antagonist (anakinra).

Rebecca Fischer-Betz1, Christoph Specker, Matthias Schneider.   

Abstract

Adult onset Still's disease (AOSD) is an uncommon, systemic, inflammatory disorder of unknown etiology, characterised by spiking fevers, skin rash, and arthritis. Treatment consists of glucocorticosteroids and immunosuppressive drugs. Over the last few years it has become increasingly evident that treatment with the IL-1 receptor antagonist (IL-1RA) anakinra is highly effective even in patients with intractable disease. So far, there are scant data available on the effects of anakinra in pregnancy. We report two patients with AOSD who successfully gave birth while treated with anakinra during pregnancy.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22153586

Source DB:  PubMed          Journal:  Clin Exp Rheumatol        ISSN: 0392-856X            Impact factor:   4.473


  16 in total

1.  Anakinra for myocarditis in juvenile idiopathic arthritis.

Authors:  Rajesh Movva; Suzanne B Brown; D Lynn Morris; Vincent M Figueredo
Journal:  Tex Heart Inst J       Date:  2013

Review 2.  Adult-onset Still's disease and pregnancy: about ten cases and review of the literature.

Authors:  M Gerfaud-Valentin; A Hot; C Huissoud; I Durieu; C Broussolle; P Seve
Journal:  Rheumatol Int       Date:  2013-04-27       Impact factor: 2.631

3.  Anakinra use during pregnancy: Report of a case with Familial Mediterranean Fever and infertility.

Authors:  Ufuk İlgen; Orhan Küçükşahin
Journal:  Eur J Rheumatol       Date:  2017-03-01

4.  Five successful pregnancies with antenatal anakinra exposure.

Authors:  Chelsey J F Smith; Christina D Chambers
Journal:  Rheumatology (Oxford)       Date:  2018-07-01       Impact factor: 7.580

5.  Fetal exposure to canakinumab: a report of three pregnancies.

Authors:  Ufuk İlgen; Şahin Eyüpoğlu; Müçteba Enes Yayla; Orhan Küçükşahin
Journal:  Clin Rheumatol       Date:  2022-01-12       Impact factor: 2.980

Review 6.  [New aspects of rare rheumatic diseases during pregnancy].

Authors:  Jörg Henes; Ann-Christin Pecher
Journal:  Z Rheumatol       Date:  2021-09-17       Impact factor: 1.372

Review 7.  Interleukin-1: an important target for perinatal neuroprotection?

Authors:  Sharmony B Kelly; Elys Green; Rod W Hunt; Claudia A Nold-Petry; Alistair J Gunn; Marcel F Nold; Robert Galinsky
Journal:  Neural Regen Res       Date:  2023-01       Impact factor: 6.058

Review 8.  Treatment of adult-onset Still's disease: a review.

Authors:  Yvan Jamilloux; Mathieu Gerfaud-Valentin; Thomas Henry; Pascal Sève
Journal:  Ther Clin Risk Manag       Date:  2014-12-22       Impact factor: 2.423

Review 9.  Management of rheumatoid arthritis during pregnancy: challenges and solutions.

Authors:  Megan L Krause; Ashima Makol
Journal:  Open Access Rheumatol       Date:  2016-03-23

Review 10.  Immunosuppressive drugs and fertility.

Authors:  Clara Leroy; Jean-Marc Rigot; Maryse Leroy; Christine Decanter; Kristell Le Mapihan; Anne-Sophie Parent; Anne-Claire Le Guillou; Ibrahim Yakoub-Agha; Sébastien Dharancy; Christian Noel; Marie-Christine Vantyghem
Journal:  Orphanet J Rare Dis       Date:  2015-10-21       Impact factor: 4.123

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.